Aeterna Zentaris Announces Evaluation and Potential Development of an Oral Prophylactic Bacterial Vaccine Against COVID-19 Through Exclusive Option Agreement with Julius-Maximilians-University Wuerzburg - Company secures next step to continue to build-out pipeline of assets. - University researchers developed a proprietary and orally active bacterial vaccine...
20 was long-term downgrade trend and 6 is strong static support.
Carnival is tanking fast and it's all hands on deck. All technical indicators say to sell and as trend traders; we trade the trend instead of going down with the ship!!
A little-known biotech is trying its hand at developing a coronavirus vaccine. Can it succeed? over the past year, Vaxart stock has soared over 1,250% because of its spot in the lucrative coronavirus vaccine race. Its stock performance even outpaced those of biotechs that have already brought their coronavirus vaccines to market, such as Moderna and...
HelloFresh is a multinational German company that delivers home, packaged in a box, the fresh ingredients of its recipes selected online by the customer to cook them in their kitchen in half an hour. HelloFresh operates in Germany, USA, Australia, Austria, Belgium, Canada, the Netherlands, Switzerland, and the United Kingdom. Its anyway strong growth...
Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test As case counts and positivity rates rise globally, the COVID-19 testing landscape is of critical importance finance.yahoo.com
PFIZER recently got FDA approval for COVID-19 Vaccine. As we see alignment of FIB key level of 0.618 and Volume Profile at this level. I would guess this would bounce back from 36-37 to new highs
My last chart: November 22, 2020: Regeneron's Coronavirus Treatment Becomes First Antibody Cocktail to Earn Emergency Use Authorization from FDA (The Motley Fool). Regeneron Covid Drug Gets Emergency OK. Antibody drug cocktail casirivimab and imdevimab are allowed for use by people over age 12 with mild or moderate Covid-19. (the street). If you are interested...
BIOV is breaking out after a series of very promising press releases concerning their COVID-19 and cancer treatment/vaccine solutions. Still under the radar and will likely see lots of upside from here.
This is an update for an ongoing $PFE position announced in an earlier post on October 2nd titled "$PFE Expect A Move Towards $41.94". Technical Analysis Currently, $PFE is still respecting the Ascending Triangle chart pattern, where after touching the slope of higher lows at around $35.50 to $36.00, it has flown past our optimal entry level of $36.36 to $36.46...
Earlier this year there was the question : How do you invest in Coronavirus vaccine stocks? Now, we have the answer : YOU DONT. Chart looking bleak, and the support lines are weak. This could be due to a few reasons: - Lack of MAINSTREAM updates - NVAX actually has no other vaccines - Market volatility due to covid and elections - Investors are seeking less...
NRG is my renewable energy choice. It has great potential for growth and is currently undervalued by at least 27% according to Yahoo finance. At this moment the stock market is seeing a huge drawback and as we near the election, markets are becoming more volatile. Currently, NRG might correct to $30 over the next few days. If $30 does not hold, next stop is $28....
Nvidia is pulling back, no prominent reason or news article that could have caused this, that leaves the next possible scenarios: - NVDA was rated overvalued by many analysts and is now drawing back - Covid market volatility is causing unpredictable movements - Upcoming US elections, many worry about the China tension According to the chart we are close to the...
If any company represents the unprecedented social, economic and technological disruptions of the coronavirus pandemic, it would have to be Zoom Video Communications. The teleconferencing stock not only joined the Nasdaq-100 in April. It’s also the index’s top gainer in 2020, up about 600 percent. Its market cap of $138 billion ranks it ahead of venerable names...
Technical Analysis Currently, $PFE is respecting an Ascending Triangle chart pattern, where buyers are unable to break the resistance level of $39.00, but has been making a slope of higher lows. As of 1/10/2020 close, the price is resting at $36.37, near the slope of higher lows. Coincidentally, we are also near the end of Wave 4, as the price is currently around...
BMRN selloff seems to be over and this is a possible entry point, some resistance at 80 but if we breach 80 we might se 88 shortly after. Very volatile market. Your thoughts.. is this a stock worth investing in? Stay safe, Ev
I am not swinging this one, even though it is tempting. I recently sold NVAX at 15% profit, and due to strong correlation with MRNA I was considering selling my MRNA as well, in which case I would have made 14% right now. However, I decided to hold because of 2 reasons : 1) AstraZeneca just took a major hit (if you don't know about it, catch up on the news)....